Dynamics of acylcarnitines, hypoglycin A, méthylènecyclopropylglycine and their metabolites in a Kladruber stallion with atypical myopathy-Reference-Cited by-同舟云学术

Dynamics of acylcarnitines, hypoglycin A, méthylènecyclopropylglycine and their metabolites in a Kladruber stallion with atypical myopathy

Published:2022-09-23 Issue:1 Volume:42 Page:183-191
ISSN:0165-2176
Container-title:Veterinary Quarterly
language:en
Short-container-title:Veterinary Quarterly

Author:

Jahn Petr¹,Dobešová Dana²,Brumarová Radana²,Tóthová Katarína¹,Kopecká Andrea¹,Friedecký David²

Affiliation:

1. Equine Clinic, Faculty of Veterinary Medicine, University of Veterinary Sciences, Brno, Czech Republic

2. Laboratory for Inherited Metabolic Disorders, Department of Clinical Biochemistry, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacký University Olomouc, Olomouc, Czech Republic

Funder

Ministry of Health of the Czech Republic

Publisher

Informa UK Limited

Subject

General Veterinary

Link

https://www.tandfonline.com/doi/pdf/10.1080/01652176.2022.2126537

Reference29 articles.

1. AlzbetaG. AlzbetaG/Metabol: First version 2019 May 30. [accessed 2022 Jul 1]. https://zenodo.org/record/3235775.

2. Detection of MCPG metabolites in horses with atypical myopathy

3. Predictive value of hypoglycin A and methylencyclopropylacetic acid conjugates in a horse with atypical myopathy in comparison to its cograzing partners

4. Hypoglycin A Content in Blood and Urine Discriminates Horses with Atypical Myopathy from Clinically Normal Horses Grazing on the Same Pasture

5. Acylcarnitines profile best predicts survival in horses with atypical myopathy

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Large-scale study of blood markers in equine atypical myopathy reveals subclinical poisoning and advances in diagnostic and prognostic criteria;Environmental Toxicology and Pharmacology;2024-09